Top infectious disease expert Dr. Anthony Fauci announced that the US is devoting $3.2 billion to advance the development of antiviral pills for COVID-19 and other dangerous viruses that could turn into pandemics.

US allocates $3.2 billion to advance development of antiviral pills for COVID-19

The government has come out with comprehensive guidelines for the management of COVID-19 among children in which Remdesivir has not been recommended and rational use of HRCT imaging has been suggested.

Indian govt issues guidelines on COVID-19 in children, says Remdesivir not recommended

India has dropped blood plasma from its treatment protocols. Now the big question is, does Remdesivir work against the virus? Watch: Over 100 patients were given fake Remdesivir injections in the Indian state of Madhya Pradesh and more than 90 per cent of them survived.

Does Remdesivir work against coronavirus?

Does Remdesivir work against the Wuhan virus, or is it overhyped? Doctors in India are prescribing it widely. This has spawned a black market for Remdesivir - where the drug is being sold for 10 times its price. WION's Palki Sharma brings you an assessment.

Gravitas: Does Remdesivir work against the Wuhan virus?

Remdesivir may soon to be dropped from COVID treatment in India. The Chairperson of one of the India's prominent hospital, Ganga Ram Hospital, has said that Remdesivir is being considered to be dropped from COVID-19 treatment.

Top Indian Hospital: Remdesivir may be dropped

Bangladesh on Thursday handed over 10,000 vials of Remdesivir injection to India as part of its medical assistance amid deteriorating COVID-19 situation in the neighbouring country. The doses of Remdesivir were produced by Beximco, one of the biggest pharmaceutical companies of Bangladesh.

Bangladesh sends 10,000 vials of Beximco's Remdesivir to India

Twelve Republican lawmakers have urged the Biden administration to not support a proposal by India and South Africa to the World Trade Organisation to temporary waive some Trade-Related Aspects of Intellectual Property Rights (TRIPS) rules amid the coronavirus pandemic.

Covid-19: 12 Republican lawmakers urge Biden admin to not support India's proposal at WTO

India has given emergency use authorization for a COVID-19 antibody-drug cocktail developed by Roche and Regeneron, expanding its arsenal of drugs to battle a massive second wave of infections.

India approves Roche/Regeneron antibody cocktail to treat COVID-19

Amid the panic on shortage of Remdesivir injections, experts have pointed out that certain steroids and blood thinners were saving life of moderate to severely affected COVID-19 stricken people.

Experts: Steroids & blood thinners crucial to save lives

Indian government has placed orders for import of 4,50,000 vials of antiviral drug Remdesivir with the first consignment of 75,000 vials expected to reach Indian shores on Friday, the Chemicals and Fertilisers Ministry said in a statement.

India to import 450,000 vials of antiviral drug Remdesivir amid spike in COVID-19 cases

Gilead Sciences Inc said on Monday it will give India at least 450,000 vials of its antiviral drug remdesivir and help boost production, as the world`s second-most populous country reels from surging coronavirus cases.

Gilead to help speed up Remdesivir availability in India

Even as the Covid crisis wreaks havoc in India, the country is all set to get essential supplies from Remdesivir to oxygen to containers from a whole host of countries.

Amid Covid surge, India looking to get Remdesivir, oxygen from several countries 

Amid a steep spike in COVID-19 cases leading to increased demand for medicines to treat coronavirus, top health experts in the government on Monday said anti-viral drug remdesivir is "not a magic bullet" and does not reduce mortality.

Remdesivir not magic bullet, does not reduce mortality against COVID-19, say health experts

Maharashtra will face a shortage of 12,000 to 15,000 Remdesivir injections, used to treat COVID-19 patients, for the next two to three days, state Food and Drug Administration (FDA) Minister Rajendra Shingane said on Friday.

Maharashtra to face shortage of Remdesivir for next 2 to 3 days: Minister 

A team of researchers from India and the US has identified that the drug Rapamycin, which is generally used to prevent rejection of transplanted organs, by suppressing the body’s immune system, can be repurposed to treat Covid-19 patients.

Researchers explore the potential of Rapamycin drug in treating aged, obese Covid-19 patients

Indian Foreign Secretary Harsh Shringla has assured Kathmandu on the covid vaccine even as both sides have agreed to "advance cooperation" in several areas. FS's visit is currently on a 2 day Nepal visit, 3rd major in-person visit from India to Nepal, after the visit of the RAW chief and Indian Army chief's visit.

Foreign Secretary Harsh Shringla assures Nepal on vaccine; both agree to advance cooperation

The World Health Organization has advised against the use of Gilead's remdesivir for patients hospitalised with Covid-19, saying there is a shortage of evidence that it improves the condition or reduces mortality.

WHO recommends against use of remdesivir for Covid-19 hospitalised patients

Demand for COVID-19 antiviral drug Remdesivir is rising sharply in India, a top executive at drugmaker Cipla Ltd said on Monday, even as experts remain divided over its effectiveness.

Indian demand for COVID-19 drug Remdesivir rising sharply: Cipla

The US Food and Drug Administration on Thursday approved Gilead Sciences Inc's antiviral drug remdesivir for treating patients hospitalized with COVID-19, making it the first and only drug approved for the disease in the United States.

Remdesivir gets US FDA approval for hospitalized COVID-19 patients

Gilead Science's antiviral drug remdesivir has been given the green light by the Food and Drug Administration as the first officially approved COVID-19 treatment.

FDA approves remdesivir as first COVID-19 treatment

The World Health Organization (WHO) has said that remdesivir has had little or no effect on coronavirus patients' length of hospital stay or chances of survival.

Remdesivir did not cut hospital stay or mortality in virus patients: WHO

As part of India's contribution to help "friendly neighbour" Myanmar in its fight against COVID-19, Army chief Gen. M M Naravane and Foreign Secretary Harsh Vardhan Shringla on Monday handed over 3,000 vials of Remdesivir to State Counsellor Aung San Suu Kyi.

India gives 3,000 vials of Remdesivir to 'friendly' Myanmar to help fight COVID-19

Sean P. Conley, the doctor taking care of the US President Donald Trump, has issued another nightly updateof Trump's recovery from the novel coronavirus. He claims that Trump has made "substantial progress since diagnosis".

Trump 'not yet out of woods'; completes second dose of Remdesivir: Doctor

Zydus Cadila on Thursday launched the cheapest generic version of Gilead Sciences' antiviral drug Remdesivir in India to treat COVID-19 following reports of shortages at hospitals.

Zydus Cadila launches India's cheapest Remdesivir version at $37 per vial

remdesivir

Remdesivir, News on Remdesivir, stories on Remdesivir, articles on Remdesivir, Remdesivir stories at Wion, Remdesivir news, Remdesivir latest news